跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 150 条关于
“WuXi PharmaTech”
全部
150
临床试验
10
药物
38
机构
16
资讯
86
17年前
WuXi PharmaTech Strengthens Board with Strategic Appointments of Industry Veterans
6个月前
D&D Pharmatech and First Bio Secure European Patent for Novel Brain Disease Drug NLY02
4个月前
D&D Pharmatech Raises $165M as MASH Drug DD01 Approaches Key Phase 2 Readout
2个月前
University of Naples Federico II Launches PharmaTech Academy 2026–2027 for RNA and Gene Therapy Workforce Training
上个月
WuXi Biologics Recognized Among Industry Leaders for Sustainable Biopharma Practices
去年
WuXi Companies Consider Asset Sales Amid US BIOSECURE Act Pressure
去年
WuXi AppTec Predicts Shift from Antibodies to Peptides in Radiopharmaceutical Development
去年
WuXi XDC Completes Singapore Manufacturing Facility, Expanding Global Bioconjugate Production Network
8个月前
HanchorBio Partners with WuXi Biologics to Accelerate Next-Generation Fusion Protein Development
去年
D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01
第 1 页,共 9 页
上一页
下一页